医学
奥司他韦
神经氨酸酶抑制剂
重症监护医学
病毒学
2019年冠状病毒病(COVID-19)
内科学
疾病
传染病(医学专业)
作者
Chunping Gu,Yi Chen,Haobin Li,Jinshen Wang,Shuwen Liu
标识
DOI:10.1080/14656566.2024.2376660
摘要
Since the coronavirus disease 2019-mandated social distancing policy has been lifted worldwide, the circulation of influenza is expected to resume. Currently, oseltamivir is approved as the first-line agent for influenza prevention and treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI